Pattern of apoptosis by NS398, a selective COX-2 inhibitor, in hepatocellular carcinoma cell lines
Mi Kyung Park1, Moon Kyu Kim, Jung Chul Kim
1Department of Immunology, School of Medicine, Kyungpook National University, Daegu, Korea.
Purpose:
NS398, a selective COX-2 inhibitor, is known to inhibit the growth of COX-2 expressing hepatocellular carcinoma cells. The present study investigated whether the cytotoxic effect of NS398 was COX-2 dependent and whether caspases were involved in NS398-induced apoptosis in hepatocellular carcinoma cells.
Materials And Methods:
The expressions of COX-2 in SNU 423 and SNU 449 hepatocellular carcinoma cell lines were examined using RT-PCR and Western blot. The cytotoxic effect of NS398 was measured using MTT in the presence or absence of caspase inhibitors. The distribution of the cell cycle and extent of apoptosis were analyzed using flow cytometry and a Cell Death Elisa kit, respectively.
Results:
The expression of COX-2 was observed in SNU423 cells, but not in SNU 449 cells. NS398 treatment resulted in both dose-and time-dependent growth inhibitions, with increases in apoptotic cells in both cell lines. Treatment with the pan-caspase inhibitor, z-VAD- fmk, or the caspase-3 inhibitor, Ac-DMQD-CHO, showed no attenuation of the cytotoxic effect of NS398 in either cell line.
Conclusion:
This study demonstrated that the cytotoxic effect of NS398 was independent of COX-2 expression. Caspases were also shown not to be involved in NS398-induced apoptosis in either SNU 423 or SNU 449 Korean HCC cell lines. Our data suggests the feasibility of preventing hepatocellular carcinoma with the use of COX-2 inhibitors needs to be carefully evaluated.
Insights
The cytotoxic effect of NS398 on hepatocellular carcinoma cells was independent of COX-2 expression and did not involve caspases. Further research is needed to evaluate COX-2 inhibitors for cancer prevention.
Area of Science:
- Oncology
- Pharmacology
- Molecular Biology
Background:
- Hepatocellular carcinoma (HCC) is a significant global health concern.
- Selective cyclooxygenase-2 (COX-2) inhibitors, like NS398, have shown potential in inhibiting the growth of COX-2 expressing HCC cells.
Purpose of the Study:
- To investigate if the cytotoxic effect of NS398 is dependent on COX-2 expression in HCC cells.
- To determine the involvement of caspases in NS398-induced apoptosis in HCC cells.
Main Methods:
- RT-PCR and Western blot were used to assess COX-2 expression in SNU 423 and SNU 449 HCC cell lines.
- MTT assays measured cytotoxicity in the presence or absence of caspase inhibitors.
- Flow cytometry and a Cell Death ELISA kit analyzed cell cycle distribution and apoptosis.
Main Results:
- COX-2 expression was detected in SNU 423 cells but not in SNU 449 cells.
- NS398 induced dose- and time-dependent growth inhibition and apoptosis in both cell lines.
- Caspase inhibitors (z-VAD-fmk and Ac-DMQD-CHO) did not attenuate the cytotoxic effect of NS398.
Conclusions:
- The cytotoxic effects of NS398 on HCC cells are independent of COX-2 expression.
- Caspases are not involved in NS398-induced apoptosis in these HCC cell lines.
- The utility of COX-2 inhibitors for HCC prevention requires careful evaluation.
Related Concept Videos
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Apoptosis
Inhibition of Cdk Activity

